Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 325 results for "cadila healthcare"

SBI-Bharatiya Mahila Bank merger gets competition commission nod and other top corporate news of the day
India Infoline

SBI-Bharatiya Mahila Bank merger gets competition commission n...

The US-based subsidiaries of two domestic drug firms — Sun Pharma and Cadila Healthcare — are recalling one product each from the market on account of failure to meet the desired specification norms. (BS) Tata Power will sell its 30% stake in ... India Infoline, 1 week ago
[x]  

58 images for cadila healthcare

Livemint.com, 1 week ago
IANS Live, 2 weeks ago
Sahara Samay.com, 2 weeks ago
Livemint.com, 3 weeks ago
Times of India, 7 hours ago
Money Control, 3 weeks ago
Livemint.com, 1 week ago
Indian Television, 2 weeks ago
India Infoline, 2 months ago
United News of India, 1 month ago

Cadila Healthcare corrects on profit booking

 Business Standard India1 week ago CADILA HEALTHCARE : corrects on profit booking  4 Traders1 week ago Cadila Healthcare slides after weak Q2 results  Capital Market1 month ago Cadila Healthcare inches up after signing in-licensing deal with Neovii  KJMC Group2 months ago
[x]  

Allergan settles patent litigation with Zydus Pharma and Cadila regarding

Allergan plc. ( AGN ) said Friday it has settled patent litigation with Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd, regarding its Delzicol (mesalamine) product, a treatment for ulcerative colitis. If the Food and Drugs Administration ...
 TD Ameritrade1 week ago Allergan settles with Zydus and Cadila over Delzicol: 4 things to know  Beckers ASC Review5 days ago Zydus announces settlement of patent litigation  India Infoline1 week ago CADILA HEALTHCARE : Zydus announces settlement of patent litigation  4 Traders1 week ago
[x]  
Freshnews.com

Japanese Encephalitis Pipeline Review H2 2016: Stage of Development and Molecule Type Analysis

(Before It's News) Japanese Encephalitis therapeutics industry report provides comprehensive information on the therapeutics under development for Japanese Encephalitis, complete with analysis by stage of development, drug target, mechanism of ...
 Before It's News5 days ago Rubella H2 2016 Therapeutics Review Featuring Drug Profiles, Latest Dormant Projects, Product Development, News & Press Releases  Before It's News1 week ago Procarbazine Market Growth by Manufacturers, Regions, Type and Application, Analysis to 2021  Before It's News3 weeks ago Genital Warts (Condylomata Acuminata) Therapeutics Industry Report H2 2016 - Latest News and Press Releases  Before It's News3 weeks ago
[x]  

Franklin India Prima Plus: Eye on superior returns

In times of high volatility in markets, investing in schemes which have clear focus on quality companies that generate superior return ratios and have wealth-creating strategies in place is a must. Among multi-cap schemes, Franklin India Prima Plus ...
 Economic Times5 days ago Fund Review: Franklin India Prima Plus delivers superior returns consistently  Economic Times5 days ago

Seshasayee Paper and Boards informs about company updates

Gala Print City informs about details of voting through postal ballot Full Article | 11:19 AM 03-Dec-2016 Celestial Biolabs submits disclosure Full Article | 11:18 AM 03-Dec-2016 Cosyn informs about company updates Full Article | 11:17 AM ...
 Finalaya.com1 week ago
Indiatimes

27 Medicines Sold By Top Firms Fail Quality Test, Know The Names

2016-12-02 17:12 2016-12-02 17:12 Source:The Indian Express | Image Courtesy: ladee4 Medicines are a boon to humanity as they cure many diseases. They have been a consistent companion of man since ages. With the advent of technology and our ...
 The Logical Indian1 week ago These 27 Medicines Sold In India Have Failed Quality Tests  Indiatimes1 week ago 27 medicines from top pharma companies are 'substandard': drug authorities of 7 states  India TV1 week ago Drug regulation: 27 medicines sold by top firms fail quality tests in seven states  Indian Express1 week ago
PharmaCompass

Teva to market cannabis inhaler; FDA makes quality metrics voluntary

View: 395 This week, Phispers brings you news on J&J's plans to acquire Actelion and Teva's new medical cannabis inhaler due for launch in Israel. There are pharma deals from across the globe, such as Roche's decision to sell its South Carolina ...
 PharmaCompass1 week ago

Non-Alcoholic Steato Hepatitis (NASH) Market - Demands, Trends, Revenue, Industry Analysis, Growth, and Forecast

Non-Alcoholic Steato Hepatitis (NASH) Market analysis is provided for global market including development trends by regions, competitive analysis of the Non-Alcoholic Steato Hepatitis (NASH) market. Non-Alcoholic Steato Hepatitis (NASH) ...
 Before It's News1 week ago Erythropoietin Drug Market Research Report- Forecast To 2027  SlideShare.net1 week ago Erythropoietin Drug Market Share, Growth, Industry Major Players Forecast to 2027  Before It's News2 weeks ago Erythropoietin Drug Market Share, Supply, Manufacturers, Consumption and Industry Growth Report to 2027  TradingCharts.com2 weeks ago

Delhi High Court Quashes Government Ban On Fixed Dose Combination Drugs

Indian pharmaceutical companies got some relief from the Delhi High Court on Thursday, after it quashed a government order banning 344 Fixed Dose Combination (FDC) drugs. The court was hearing a plea filed by pharmaceutical companies challenging ...
 Bloomberg-Quint1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less